Escherichia coli from Human Wounds: Analysis of Resistance to β-Lactams and Expression of RND Efflux Pumps
Open Access
- 1 November 2023
- journal article
- research article
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 16, 7365-7375
Abstract
Purpose: Resistance of pathogenic strains of Escherichia coli to β-lactams, particularly to ampicillin, is on the rise and it is attributed to intrinsic and acquired mechanisms. One important factor contributing to resistance, together with primarily resistance mechanisms, is a mutation and/or an over-expression of the intrinsic efflux pumps in the resistance-nodulation-division (RND) superfamily. Among these efflux pumps, AcrA, AcrB, TolC, and AcrD play an important role in antimicrobial co-resistance, including resistance to β-lactams. Materials and Methods: Twelve E. coli isolates obtained from patients’ wounds and the control strain of E. coli ATCC 25922 were analyzed. The phenotypic resistance of these isolates to selected β-lactams was assessed by determination of the minimal inhibitory concentration. Additionally, the prevalence of β-lactamase genes (blaTEM, blaCTX-M, blaSHV, and blaAmpC) was screened by PCR. Real-time qPCR was used to determine the expression of the selected efflux pumps acrA, acrB, tolC, and acrD and the repressor acrR after the exposure of E. coli to ampicillin. Results: Phenotypic resistance to β-lactams was detected in seven isolates, mainly to ampicillin and piperacillin. This was corroborated by the presence of at least one acquired bla gene in each of these isolates. Although E. coli strains varied in the expression of RND-family efflux pumps after the ampicillin exposure, their gene expression indicated that these pumps did not play a major role in the phenotypic resistance to ampicillin. Conclusion: Each E. coli isolate displayed unique characteristics, differing in minimum inhibitory concentration (MIC) values, prevalence of acquired blaTEM and blaCTX-M genes, and expression of the RND-family pumps. This together demonstrates that these clinical isolates employed distinct intrinsic or acquired resistance pathways for their defense against ampicillin. The prevalence and spread of ampicillin resistant E. coli has to be monitored and the search for ampicillin alternatives is needed.Keywords
This publication has 65 references indexed in Scilit:
- ESBL, MBL and Ampc Lactamases Producing Superbugs – Havoc in the Intensive Care Units of Punjab IndiaJournal of Clinical and Diagnostic Research, 2013
- Antimicrobial Drug Resistance in Escherichia coli from Humans and Food Animals, United States, 1950–2002Emerging Infectious Diseases, 2012
- Expression of Multidrug Efflux Pump Genes acrAB-tolC , mdfA , and norE in Escherichia coli Clinical Isolates as a Function of Fluoroquinolone and Multidrug ResistanceAntimicrobial Agents and Chemotherapy, 2011
- Correlation of Overexpression of Efflux Pump Genes with Antibiotic Resistance inEscherichia coliStrains Clinically Isolated from Urinary Tract Infection PatientsJournal of Clinical Microbiology, 2011
- Distribution of bla TEM , bla SHV , bla CTX-M Genes Among Clinical Isolates of Klebsiella pneumoniae at Labbafinejad Hospital, Tehran, IranMicrobial Drug Resistance, 2010
- Efflux-Mediated Drug Resistance in BacteriaDrugs, 2009
- AmpC β-LactamasesClinical Microbiology Reviews, 2009
- Crystal Structure of the Transcriptional Regulator AcrR from Escherichia coliJournal of Molecular Biology, 2007
- Substrate Specificity of the RND-Type Multidrug Efflux Pumps AcrB and AcrD of Escherichia coli Is Determined Predominately by Two Large Periplasmic LoopsJournal of Bacteriology, 2002
- Nucleotide sequences of the genes coding for the TEM-like β-lactamases IRT-1 and IRT-2 (formerly called TRI-1 and TRI-2)FEMS Microbiology Letters, 1994